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Premature anaphase onset is prevented by the
mitotic checkpoint through production of a ‘‘wait
anaphase’’ inhibitor(s) that blocks recognition of
cyclin B and securin by Cdc20-activated APC/C,
an E3 ubiquitin ligase that targets them for destruc-
tion. Using physiologically relevant levels of Mad2,
Bub3, BubR1, and Cdc20, we demonstrate that
unattached kinetochores on purified chromosomes
catalytically generate a diffusible Cdc20 inhibitor or
inhibit Cdc20 already bound to APC/C. Furthermore,
the chromosome-produced inhibitor requires both
recruitment of Mad2 by Mad1 that is stably bound
at unattached kinetochores and dimerization-
competent Mad2. We show that purified chromo-
somes promote BubR1 binding to APC/C-Cdc20 by
acting directly on Mad2, but not BubR1. Our results
support a model in which immobilized Mad1/Mad2
at kinetochores provides a template for initial
assembly of Mad2 bound to Cdc20 that is then con-
verted to a final mitotic checkpoint inhibitor with
Cdc20 bound to BubR1.
INTRODUCTION
To ensure accurate segregation, the major cell cycle control
mechanism in mitosis, the mitotic checkpoint (or the spindle
assembly checkpoint), delays anaphase onset until all chromo-
somes have properly attached to spindle microtubules. The
checkpoint-derived inhibitor(s) blocks premature destruction
of key mitotic components. This is achieved by selectively inhib-
iting Cdc20-stimulated recognition of the mitotic regulators
cyclin B and securin by a multisubunit E3 ubiquitin ligase, the
anaphase-promoting complex/cyclosome (APC/C). Checkpoint
silencing and subsequent deactivation of the checkpoint arrest
releases APC/CCdc20 for ubiquitination of cyclin B and securin,
with anaphase triggered by their degradation by the proteosome
(reviewed in Peters, 2006).DevelopBy correlating the timing of anaphase onset with spindle
microtubule capture by the last unattached chromosome (Rieder
et al., 1994), laser ablation of the last unattached kinetochore
(Rieder et al., 1995), and micromanipulation (Li and Nicklas,
1995), researchers first implicated unattached kinetochores as
essential for generation of the ‘‘wait anaphase’’ inhibitor. Key
proteins essential for mitotic checkpoint signaling include
Mad1, Mad2, Bub3, CENP-E, Zw10, Rod, and the kinases
Mps1, Bub1, and BubR1 (reviewed by Musacchio and Salmon,
2007), each of which is at least transiently localized to unat-
tached kinetochores during earlymitosis. Fluorescence recovery
after photobleaching (FRAP) demonstrated that Mad2, BubR1,
and Cdc20 cycle on and off kinetochores rapidly (Howell et al.,
2000, 2004; Kallio et al., 2002; Shah et al., 2004). Additionally,
several APC/C subunits are at least partially localized onto unat-
tached kinetochores (Acquaviva et al., 2004; Jorgensen et al.,
1998), supporting the possibility that one or more of its compo-
nents are sensitized for checkpoint inhibition there.
Inhibition of Cdc20 activation of APC/C has previously been
attributed to Mad2 (Fang et al., 1998a) or BubR1 (Tang et al.,
2001), both of which can bind Cdc20 directly and in so doing
have been shown to reduce APC/CCdc20 ubiquitination activity
accordingly. A complex, named the mitotic checkpoint complex
(MCC) and proposed to comprise Mad2, BubR1, Bub3 and
Cdc20, has been reported to inhibit APC/C much more potently
than Mad2 alone (Sudakin et al., 2001). However, the existence
of MCC-like complexes has been noted outside of mitosis (Su-
dakin et al., 2001) or in the absence of a functional kinetochore
(Fraschini et al., 2001). The simplest view is that an interphase
mechanism independent of kinetochores generates a premade
inhibitor(s) of Cdc20 that requires Mad2 and BubR1 and whose
half-life sets a minimum time before anaphase onset (Meraldi
et al., 2004).
A ‘‘template’’ model for kinetochore-dependent activation of
Mad2 (De Antoni et al., 2005), a modified version of the ‘‘two-
state’’ model (Yu, 2006), has emerged from use of cultured cells,
purified components in the absence of chromosomes, and the
discovery that Mad2 can undergo a large conformational change
in which its carboxy-terminal ‘‘seatbelt’’ domain encloses either
Mad1 or Cdc20, thereby converting the initial Mad2 from an
‘‘open’’ (or ‘‘N1’’) to a ‘‘closed’’ (or ‘‘N2’’) conformation (Luo
et al., 2000, 2002, 2004; Sironi et al., 2002, 2001). The closedmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc. 105
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binding to and activating APC/C for recognition of cyclin B
through direct capture of Cdc20 by Mad2 (Luo et al., 2004). The
carboxy-terminal domain of Mad1 has been shown to directly
bind a molecule of Mad2 in the closed conformation (Luo et al.,
2002, 2004; Sironi et al., 2002, 2001). FRAP has revealed that
Mad1 at kinetochores, presumably bound to Mad2, is nonex-
changeable,while twoequally sizedpools of kinetochore-associ-
ated Mad2 either cycle on and off rapidly (within a few seconds)
or are more stably bound (Shah et al., 2004). Mad2 mutants
impaired in dimerization were subsequently shown to be unable
to support either mitotic checkpoint signaling in vivo (De Antoni
et al., 2005; Mapelli et al., 2006; Nezi et al., 2006) or capture of
Cdc20 (using a 27 amino acid peptide to mimic Cdc20) by
Mad2 in acomplexwith a 233amino acidMad2-binding fragment
of Mad1 (De Antoni et al., 2005; Nezi et al., 2006).
Use of in vitro FRAP demonstrated recruitment of a rapidly
exchangeableMad2 by a second stably associatedMad2 bound
in the closed conformation to full-length or a fragment of Mad1
(Vink et al., 2006). There is, however, no evidence for facilitating
conversion of soluble Mad2 to Mad2-Cdc20, and the rate of
Mad2 dissociation from the immobilizedMad1/Mad2 is indepen-
dent of the Cdc20 peptide (Vink et al., 2006). Moreover, the
majority of the cellular Mad2, which is present at approximately
equimolar concentrations to Cdc20 during mitosis (Tang et al.,
2001), remains in the open conformation that is less capable of
interacting with Cdc20 (Luo et al., 2004). Thus, neither the iden-
tity(ies) of the checkpoint-derived wait anaphase inhibitor nor
how unattached kinetochores participate in its production is
established. We have now used purified components to deter-
mine that unattached kinetochores catalyze production of
a diffusible wait anaphase inhibitor by using a Mad2 template
to prime Cdc20 for BubR1 binding.
RESULTS
Mad2 Recruitment to Unattached Kinetochores
on Purified Chromosomes
To reconstruct kinetochore-mediated mitotic checkpoint
signalingwith all purifiedcomponents, successive sucrosegradi-
ents were used to isolate chromosomes with unattached kineto-
chores from colcemid-arrested, mitotic HeLa cells stably ex-
pressing histone H2B-YFP (Figure 1A). Morphologically intact,
condensed chromosomes were obtained, as observed by YFP
fluorescence of unfixed chromosomes (Figure 1B). Tubulin was
reduced to less than 1/40th of its concentration in the initial
cell extracts (Figure 1D), while histones (including H2B-YFP and
the mitotic-specific phosphorylated histone H3) and kineto-
chore-associated kinesin-like motor protein CENP-E were
nearly quantitatively retained (Figure 1C). Components previ-
ously reported by FRAP to be stably bound to unattached kinet-
ochores, including Bub1 and Mad1 (Howell et al., 2004; Shah
et al., 2004), were also retained, as was Mps1 and a proportion
of Aurora B (Figure 1C).
Using anti-centromere antisera (ACA) and immunofluorescent
staining of fixed, DAPI-stained chromosomes, Bub1, Mad1, and
CENP-E were demonstrated to remain kinetochore bound
(Figure 1E). Components for which FRAP had revealed rapid
cycling, including BubR1, Bub3, and Cdc20, were undetectable106 Developmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevby immunoblotting of the purified chromosome fractions (Fig-
ure 1C) (their levels in purified chromosomes were all %1.1%
of the cytosolic levels; see Figures S1A and S1C available on-
line). Although a portion of Mad2 is known to be stably bound
at an unattached kinetochore for at least 2 min in vivo (Shah
et al., 2004), Mad2 nearly completely dissociated from most
kinetochores during the 7 hr required for chromosome isolation
(Figure 1C), with faint levels detectable by immunofluorescence
remaining only on a minority (20.1%) of isolated chromosomes
(Figure 1E).
Bacterially produced Mad2 was isolated under conditions
promoting primarily the retention of the openmonomeric confor-
mation, the conformation thought to be representative of cyto-
solic Mad2 (Luo et al., 2004; Mapelli andMusacchio, 2007). After
covalent ligation of rhodamine (Figure 1F; see Figure S3A for
activity assessment) and addition to purified chromosomes,
rhodamine-Mad2 bound to unattached kinetochores of the
majority of chromosomes (Figure 1G; see also Figure S3C for
quantification). At least a portion of this Mad2 binding was medi-
ated through kinetochore-associated Mad1, as demonstrated
by partial blocking even by brief preincubation of the chromo-
somes with an antibody against Mad1 (Figure 1H).
Generation by Unattached Kinetochores
of an APC/C-Cdc20 Inhibitor
To determine how unattached kinetochores produce a mitotic
checkpoint signal, we established an in vitro assay for Cdc20-
stimulated ubiquitination by APC/C. Human homologs of Mad2
and BubR1, as well as Bub3, Cdc20, and the APC/C G1-specific
activator Cdh1 (Fang et al., 1998b), were purified after produc-
tion in bacteria or in insect cells using baculovirus (Figures 2A
and 2B). APC/C was immunoprecipitated (Figure 2C) from Xen-
opus interphase or mitotic extracts with an antibody against
the Cdc27 subunit. Immunoblotting of mitotic APC/C revealed
slowed mobility of Cdc27 both in the initial mitotic extract and
after isolation (Figure 2G), a shift known to reflect mitotic phos-
phorylation (Kraft et al., 2003). Addition of Cdc20 to either
APC/C equivalently activated the ubiquitination of cyclin B1-102
(Figures 2E and 2H), which could be quantified either by the
presence of slower mobility cyclin B species (Figure 2E, top;
Figure 2H) or the intensity of the remaining unubiquitinated
cyclin B (Figure 2E, bottom).
Basal inhibition of APC/CCdc20 ubiquitination activity by our
purified checkpoint proteins was initially assayed in the presence
of equalmolar amounts ofMad2, BubR1, or Bub3 to approximate
the relative in vivo stoichiometries (see Figure S1). Under these
conditions addition ofMad2, Bub3, or BubR1alonedid not signif-
icantly inhibit ubiquitination of cyclin B, while the combination of
Mad2 and BubR1 did, independent of Bub3 (Figure 2E, compare
lanes 3–6 with lanes 7 and 8). Inhibition was selective for Cdc20-
mediated activation of APC/C, as similar addition to APC/CCdh1
left ubiquitination activity undiminished (Figure S2A). BubR1
was a significantly better inhibitor of Cdc20 activation of APC/
C: a >10-fold molar excess of Mad2 over Cdc20 was necessary
to achieve >50% inhibition, whereas 10 times less of BubR1
withorwithoutBub3was required for equivalentAPC/CCdc20 inhi-
bition (Figures 2J and 2K; Figure S2B). Nevertheless, there was
synergism between Bub3/BubR1 and Mad2. Inhibition by the
combination of Bub3/BubR1 and Mad2 was greater than theier Inc.
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Figure 1. Unattached Kinetochores on Purified Chromosomes Recruit Mad2
(A) Schematic of chromosome purification frommitotic HeLa cells stably expressing YFP-H2B histone. Cells were collected after 16 hr in colcemid and lysed, cell
debris was removed by pelleting, and the chromosome-containing supernatant was fractionated on sequential sucrose gradients.
(B) Morphology of purified chromosomes detected by fluorescence of YFP-H2B on coverslips without fixation.
(C) Protein constituents of purified chromosomes assessed by immunoblotting after pelleting.
(D) Tubulin levels remaining in purified chromosomes, along with a dilution series of the initial cellular input.
(E) Indirect immunofluorescence for detection of (red) Mad1, Bub1, CENP-E, or Mad2, on isolated chromosomes: (blue) chromosomes stained with DAPI; (green)
anti-centromere (ACA) antibodies; (right panel) merged image.
(F) Purified recombinant Mad2 before and after covalently labeling with rhodamine, assessed by Coomassie staining.
(G) Purified chromosomes were incubated with rhodamine-labeled Mad2, fixed, stained for (blue) DAPI and (green) ACA, and imaged by deconvolution
microscopy.
(H) Chromosomes were incubated for 10min with anti-Mad1 antibody, then with rhodamine-labeledMad2, and finally fixed, stained, imaged as in (G), and scored
for Mad2 localization.additive effect of each alone. Suppression of cyclin B ubiquitina-
tion by BubR1 was enhanced by Mad2 such that a quarter of the
amount of BubR1 was required for equivalent inhibition of Cdc20
in the presence of Mad2 (Figure S2B, lane 8 versus 13), even
though the same amount of Mad2 alone produced no inhibition
(Figure S2B, lane 6 versus 13), results similar to an earlier report
in which Mad2 and Bub3/BubR1 cooperate to inhibit Cdc20
even in the absence of unattached kinetochores (Fang, 2002).
Addition to APC/CCdc20 of increasing levels of Mad2 alone
produced dose-dependent inhibition of cyclin B ubiquitination
(Figure 2J, lanes 3–6), but even a 20-fold excess of Mad2 over
Cdc20 produced only 50% inhibition. In the absence of chromo-
somes, BubR1 yielded comparable inhibition of APC/CCdc20 at
10- to 20-fold lower levels than required for Mad2. AlthoughDeveloppurified chromosomes alone minimally inhibited APC/CCdc20,
addition of them to a concentration approximating ten unat-
tached kinetochores per cell volume amplified the inhibition
produced at all concentrations tested of added Mad2 (Fig-
ure 2J, lanes 8–11), but not BubR1 (Figure 2K). Equivalent inhibi-
tion of mitotic and interphase APC/CCdc20 by a combination of
Mad2, Bub3, and BubR1 was seen at all concentrations, both
in the presence and absence of chromosomes (Figure 2H). For
example, although equimolar additions of Mad2, Bub3, and
BubR1 produced minimal inhibition of Cdc20-dependent activa-
tion of APC/C, unattached kinetochores produced equivalent
inhibition at 10-fold lower levels of added Mad2 and BubR1/
Bub3 (Figure 2H, compare lane 1 versus 9 and lane 10 versus
18). Moreover, chromosome-dependent inhibitory activity wasmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc. 107
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Figure 2. Kinetochores Amplify Production of an APC/CCdc20 Inhibitor
(A) Purified recombinant human Cdh1, Cdc20, Mad2, Bub3, and BubR1, assessed by Coomassie staining.
(B) Purified recombinant human E1, UbcH10, and the N-terminal cyclin B, assessed by Coomassie staining.
(C) Interphase Xenopus APC/C after immunoprecipitation with immobilized antibodies to Cdc27 and visualized by silver stain.
(D) Schematic of APC/C ubiquitination activity assays.
(E) Equal molar amounts of Mad2, Bub3, and BubR1 were incubated with Cdcd20 either alone or in various combinations, in the absence of unattached kinet-
ochores. APC/C activity was assessed either as the degree of cyclin B ubiquitination (top panel) or as the depletion of the unubiquitinated pool (bottom panel).
(F–H) Kinetochores on purified chromosome amplify inhibition of mitotic APC/CCdc20. (F) Schematic of Xenopus extract preparation for isolation of mitotic APC/C
by immunoprecipitation. (G) Immunoprecipitated mitotic APC/C: hyperphosphorylation retards mobility relative to interphase APC/C after immunoblotting for
Cdc27. Hyperphosphorylation is lost upon phosphatase treatment. (H) Comparison ofmitotic and interphase APC/C activity (quantified by diminished abundance108 Developmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc.
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was unaffected even at maximal doses of Bub3/BubR1, Mad2,
and chromosomes (Figure 2I). Chromosome amplification of
APC/CCdc20 inhibition was greatest at the lowest concentrations
of added Mad2 and BubR1/Bub3, with maximal inhibition 35-
fold higher than that seen in the absence of chromosomes
(Figure 2L, 0.13 concentration).
Mad2 Dimerization Is Required for Kinetochore
Amplification of Cdc20 Inhibition
To determine if recruitment of Mad2 to unattached kinetochores
via Mad1 (Chen et al., 1998) and Mad2 binding directly to Cdc20
were required for chromosome amplification of APC/CCdc20 inhi-
bition, APC/C activity assays were performed with wild-type
Mad2 or a Mad2mutant that can bind to kinetochore-associated
Mad1 or Cdc20 but is incompetent for dimerization onto Mad1/
Mad2 complexes (Figure 3A). For this, we chose the Mad2RQ
mutant (carrying the two amino acid substitution R133E,
Q134A), previously demonstrated as incapable of supporting
full mitotic checkpoint function in vivo (De Antoni et al., 2005)
(Figures 3B and 3C). Incubation of rhodamine-labeled Mad2RQ
(Figure S3B) with purified chromosomes yielded Mad2 localiza-
tion to kinetochores with equal frequency as wild-type Mad2
(Figure S3C), yet with approximately half the intensity (Fig-
ure S3D). Thus, Mad2RQ bound directly to Mad1 at kinetochores
mostly depleted of endogenous Mad2 (Figure 1C), yet was
unable to recruit a second Mad2 molecule to form Mad2 dimers.
In the absence of chromosomes, Mad2RQ inhibited Cdc20-
stimulated APC/C ubiquitination almost as well as wild-type
Mad2 did (Figure 3D; Figure S4A). This Cdc20 inhibition required
direct binding of Mad2 to Cdc20: Mad2 mutants (Mad2DC or
Mad2RQ-DC; Figures 3B and 3C) missing the carboxy-terminal
10 amino acids that are required for Cdc20 binding (Luo et al.,
2000) did not inhibit APC/CCdc20 at any concentration (Figure 3D;
Figure S4A).
In contrast to wild-type Mad2, the dimerization-deficient
Mad2RQ was incapable of supporting chromosomal amplifica-
tion of APC/C inhibition at any added concentration (Figure 3E;
Figure S4B). Moreover, when tested for synergy with Bub3/
BubR1 and chromosomes in inhibiting APC/CCdc20, Mad2RQ
was much less efficient than wild-type Mad2 (Figure 3F;
Figure S4C), thus supporting action by kinetochores on Mad2
for amplifying generation of a Cdc20 inhibitor.
Kinetochore-BoundMad1 Is Required for Chromosome-
Mediated Amplification of a Cdc20 Inhibitor
To further test the Mad1 role in the chromosome-dependent
amplification of an APC/CCdc20 inhibitor, a Mad1 antibody raisedDevelopagainst the region that spans the Mad2-binding domain was
added to isolated chromosomes in an effort to inhibit its function
at kinetochores (Figure 3G). This substantially reduced Mad2
recruitment to kinetochores (Figure 1H), as anticipated. In the
absence of chromosomes orMad2,Mad1 antibody had no effect
on APC/CCdc20 ubiquitination (Figure 3H). In the presence of
a 5-fold excess of Mad2 (the concentration chosen for the great-
est enhancement of inhibition upon addition of chromosomes),
chromosomes amplified APC/CCdc20 inhibition 7-fold, but this
amplification was almost eliminated by Mad1 antibody addition
(Figure 3H; Figure S4D). Thus, Mad1 at kinetochores is required
both for kinetochore recruitment of Mad2 and chromosome-
mediated enhancement of inhibition of APC/CCdc20.
Kinetochore-Enhanced Inhibition of Cdc20 Bound
to APC/C
Models of APC/C inhibition in mitosis initially focused upon
sequestration of Cdc20 (Fang et al., 1998a; Tang et al., 2001)
as themodeof preventingCdc20activationofAPC/C.Analterna-
tive is inhibition by a checkpoint-derived inhibitor binding directly
to Cdc20 already bound to APC/C. To distinguish between these
models, inhibition of APC/CCdc20 activity was assessed either by
preincubation of chromosomes, Bub3/BubR1,Mad2, andCdc20
followed by addition of APC/C (Figure 4A) or by addition of
chromosomes, Bub3/BubR1, and Mad2 to Cdc20 prebound to
APC/C (Figure 4B). At all concentrations of checkpoint compo-
nents, inhibition of APC/CCdc20-mediated ubiquitination of cyclin
B1-102 was comparable following coincubation with Cdc20 or
after preactivation by binding of Cdc20 to APC/C (Figure 4C;
Figure S5). Thus, APC/CCdc20 can be directly inhibited by a kinet-
ochore-derived inhibitor(s), and a model of simple sequestration
of Cdc20 cannot be the sole means by which APC/C is held
inactive for cyclin B ubiquitination.
A Soluble Kinetochore-Derived Cdc20-BubR1-Bub3
Inhibitor
To test whether a soluble kinetochore-derived inhibitor of Cdc20
can be produced, chromosomes with unattached kinetochores
were incubated with BubR1, Bub3, Mad2, and Cdc20, but
then removed prior to the addition of APC/C (Figure 5A;
Figure S6A). In the absence of chromosomes, incubation of
Cdc20 and a low level of BubR1, Bub3, Mad2, and Cdc20,
followed by subsequent addition of APC/C, produced almost
fully active APC/CCdc20. Parallel incubation of the same amounts
of BubR1, Bub3, Mad2, and Cdc20 but now in the presence of
chromosomes amplified APC/C inhibition greater than 3-fold,
independently of whether chromosomes were removed prior toof lower mobility ubiquitin-conjugated cyclin B species) assessed after addition of increasing amounts of BubR1, Bub3, and Mad2 to Cdc20, either in the pres-
ence or absence of chromosomes.
(I) BubR1, Bub3, Mad2, and chromosomes were incubated with either (red bar) Cdc20 or (blue bar) Cdh1 activators, prior to APC/C activity determination. Incu-
bations with Cdc20 rendered the APC/C almost fully inactive, while Cdh1 incubations had no effect on the activity of APC/C.
(J–L) Chromosomes (blue squares) at a final concentration equaling ten unattached kinetochores per cell volume or just buffer (red triangles) were added to
increasing concentrations of (J) Mad2, (K) Bub3/BubR1, or (L) both, incubated for 1 hr prior to addition of APC/C, and then assayed for APC/C ubiquitination
of myc-cyclin B1-102. APC/C activity was quantified by the intensity of remaining unubiquitinated cyclin B. Mad2 inhibition of APC/C in the presence of chromo-
somes increased, while BubR1 inhibition remained unchanged. Chromosomes further amplified APC/C inhibition when added to the combination of Mad2,
BubR1, and Bub3 at physiological concentrations.
Error bars represent standard error of the mean calculated from at least three independent assays.mental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc. 109
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Figure 3. Mad1-Dependent Mad2 Conformational Change and Dimerization Are Required for Kinetochore-Mediated Amplification of
a Cdc20 Inhibitor
(A) Schematic of Mad2 template model (De Antoni et al., 2005).
(B) Table of Mad2 mutant properties (De Antoni et al., 2005; Fang et al., 1998a; Luo et al., 2000, 2004; Sironi et al., 2002).
(C) Purified recombinant human Mad2DC, Mad2RQ, and Mad2RQ-DC visualized by Coomassie staining.
(D) Increasing quantities of (red triangles) Mad2wt, (blue squares) Mad2DC, (green circles) Mad2RQ, or (yellow diamonds) Mad2RQ-DC were incubated for 1 hr with
Cdc20 prior to APC/C addition and assayed for APC/C ubiquitination of myc-cyclin B1-102.
(E) Mad2RQ inhibition of Cdc20 activation of APC/C assessed after incubating increasing quantities with Cdc20 either in the (blue squares) presence or (red trian-
gles) absence of chromosomes before assaying cyclin B ubiquitination.
(F) Testing chromosome amplification of a Cdc20 inhibitor after increasing concentrations of (green circles) Mad2RQ or (blue squares) Mad2wt, along with BubR1,
Bub3, and Cdc20, either in the presence or (red triangles) absence of chromosomes.
(G and H) (G) Purified chromosomes were incubated with Mad1 antibody for 1 hr prior to addition of a 5-fold excess of Mad2 to Cdc20, and finally addition to
APC/C ubiquitination assays, and (H) inhibition of APC/CCdc20 was measured.
Error bars represent standard error of the mean calculated from at least three independent assays.APC/C addition. Thus, a soluble inhibitor(s) amplified by unat-
tached kinetochores is produced independently of APC/C.
Unattached Kinetochores Act on Mad2 to Amplify
a Cdc20 Inhibitor
To test if unattached kinetochores act directly onMad2, chromo-
somes andCdc20were incubated withMad2, the chromosomes
were then removed, BubR1/Bub3 was added, and finally APC/C
was added and assayed for ubiquitination of cyclin B. Compa-
rable to the stimulated inhibition of Cdc20 found when all
components were incubated together with chromosomes
(Figures 2L and 5A), a 4-fold stimulation of inhibitory activity
was generated when only Mad2 and Cdc20 were coincubated
with chromosomes (Figure 5B; Figure S6B). Thus, amplification
of a Cdc20 inhibitor with purified components does not require
unattached kinetochores acting directly on either APC/C or
BubR1/Bub3, but rather can be produced by direct interaction
with Mad2 and/or Cdc20.110 Developmental Cell 16, 105–117, January 20, 2009 ª2009 ElsevCatalytic Production by Unattached Kinetochores
of a Mad2 Cdc20 Inhibitor
A central unresolved question is whether unattached kineto-
chores act catalytically in the production of a Cdc20 inhibitor.
A central requirement of a catalytic model would be for unat-
tached kinetochores to accelerate the rate of production of
a Cdc20 inhibitor, while an extended incubation without kineto-
chores could ultimately yield comparable inhibition mediated
by an uncatalyzed, spontaneous process. To test the catalytic
model, Mad2 and Cdc20 were added to a level sufficient to yield
40% inhibition after extended incubation without addition of
chromosomes. In theabsenceof chromosomes, a linear increase
in inhibition of Cdc20 was produced over the first 120 min, ulti-
mately plateauing at about 40% inhibition by 4 hr (Figure 5C;
Figure S6C). As required for chromosome-dependent catalysis,
the presence of a concentration of chromosomes corresponding
to ten unattached kinetochores per cell accelerated the initial rate
of inhibitor production 8-fold (initial slopes of 2.5 versus 0.3%
inhibition/min in the presence and absence of chromosomes,ier Inc.
Developmental Cell
Catalytic Kinetochores Generate a Cdc20 Inhibitorrespectively) (Figure 5C), with the final level of inhibition similar to
that produced spontaneously.
Kinetochores Facilitate Bub3/BubR1 Binding
to APC/CCdc20
To probe whether the unattached kinetochores on purified chro-
mosomes altered the composition of proteins bound to APC/C,
a peptide-derived antibody to Cdc27 (Herzog and Peters,
2005) was used to affinity purify APC/C. After preincubation of
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(A) Checkpoint components including Cdc20 and chromosomes were incu-
bated, followed by addition of APC/C and assay for its activity.
(B) Immunoprecipitated APC/C was first incubated with Cdc20 to form an
active complex (‘‘Pre-activated APC/C’’). APC/C was affinity recovered and
subsequently incubated with chromosomes and increasing amounts of
BubR1, Bub3, and Mad2, and APC/C activity was assayed.
(C) Quantitation of (red triangles) coincubated and (blue squares) preactivated
Cdc20-stimulated APC/C activity.
Error bars represent standard error of the mean calculated from at least three
independent assays.DevelopCdc20, BubR1, Bub3, Mad2, and chromosomes, bead-bound
APC/C was added, the beads were recovered, and APC/C and
proteins bound to it were released by addition of a competing
Cdc27 peptide. Immunoblotting revealed that similar amounts
of Cdc20 coimmunoprecipitated with APC/C regardless of
the concentrations of coincubated checkpoint components
(Figure 6A).
While a proportion of Mad2 has previously been reported to be
associated with APC/C (Fang et al., 1998a; Kallio et al., 1998),
Mad2 binding to APC/C was not Cdc20 dependent (lane 11).
A small, variable proportion of Mad2 and Mad2RQ bound to
APC/C independently of chromosomes, revealing a direct affinity
of Mad2 for APC/C that wasmodestly increased by the presence
of chromosomes (Figures 6A, 6D, and 6E). Neither BubR1 nor
Bub3 bound APC/C in the absence of Mad2. Bub3/BubR1 did,
however, bind to APC/C in a Mad2-dependent manner that at all
concentrations tested was further enhanced by up to 4-fold by
chromosomes (Figure 6A, compare lane 4 with lanes 9 and 10;
Figures 6B and 6C). However, the number of BubR1 molecules
bound to APC/CCdc20 after incubation with chromosomes was
always greater than the number of bound Mad2 molecules,
as seen by a stoichiometry of greater than 1:1 (Figure 6E), incon-
sistent with MCC-like complexes that would contain equal
stoichiometries of Mad2 and BubR1/Bub3. This chromosome-
enhancedBubR1/Bub3 bindingwas not supported by the dimer-
ization-incompetent Mad2RQ (Figure 6A, lane 13 versus 15;
Figures 6B, 6C, and 6E). Sucrose gradient sedimentation of the
complexes released from the initial antibody-coated beads
confirmed a 2- to 3-fold, chromosome-dependent increase in
BubR1/Bub3 bound to APC/C (Figure 6F). Thus, Bub3/BubR1
binding to APC/C is facilitated by dimerization-competent
Mad2 and unattached kinetochores through a mechanism that
does not affect Cdc20 interaction with APC/C.
A Soluble Kinetochore-Derived Cdc20-BubR1-Bub3
Inhibitor
To determine the composition(s) of complexes produced spon-
taneously or by action of unattached kinetochores in the
absence of APC/C, equal stoichiometries of various combina-
tions of BubR1, Bub3, Mad2, and Cdc20 were incubated with
or without purified chromosomes, the chromosomes were
removed, and the inhibitor-containing supernatant (as in
Figure 4A) was subjected to size-exclusion chromatography.
As expected, Bub3 shifted into a larger complex, coeluting
with BubR1 under all conditions. Most Cdc20 shifted into
a substantially higher molecular weight complex both in the
presence (Figure 7E) and absence (Figure 7D) of chromosomes,
eluting together with BubR1 and Bub3 (centered on fractions 12
and 13). Except for a small proportion of Mad2 bound to Cdc20
when incubated alone with it (Figure 7C), surprisingly little Mad2
chromatographed with Cdc20 under any condition, eluting
instead at a position corresponding to a Mad2 monomeric
form, regardless of the presence of chromosomes and/or
BubR1/Bub3. Very little Mad2 was found in an MCC-like tetra-
meric complex with BubR1, Bub3, and Cdc20 in the absence
of chromosomes, even when using conditions that produced
up to 80% inhibition of Cdc20’s ability to activate APC/C
(Figure 2L). Incubation with chromosomes eliminated even
this small amount of MCC-like complex (Figures 7D and 7E).mental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc. 111
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Figure 5. Catalytic Production by Unattached Kinetochores of a Diffusible Cdc20 Inhibitor through Sequential Involvement of Mad2 and
BubR1
(A) Chromosomeswere incubated with BubR1, Bub3,Mad2, and Cdc20 (1:1:1:5); the chromosomes were subsequently removed by centrifugation, and (blue) the
supernatant fraction was assayed for activation of APC/C for cyclin B ubiquitination. A parallel assay was done (red) without chromosome removal or (white)
without initial chromosome addition.
(B) Chromosomes were initially incubated with Mad2 and Cdc20 (1:5); the chromosomes were subsequently removed, and BubR1/Bub3 added to the superna-
tant fraction after chromosome removal (green). The resulting ubiquitination activity was compared to (blue) inhibition produced by incubating chromosomes with
Mad2, BubR1, and Bub3 prior to chromosome removal or (white) no chromosomes added.
(C) Cdc20 was incubated with a 5-fold excessMad2 and chromosomes. At the indicated time points, (blue squares) a fraction of the incubation was removed and
assayed for APC/C activity. Chromosome-mediated catalysis was compared to (red triangles) chromosome-independent inhibitor production over time.
Error bars represent standard error of the mean calculated from at least three independent assays.On the other hand, incubation with chromosomes produced
a proportion of BubR1 and Cdc20 that eluted earlier (e.g., frac-
tion 11), consistent with production of a larger complex or one
with a more extended structure so as to produce a higher
Stoke’s radius. This complex was comprised of approximately
equal molar amounts of BubR1 and Cdc20, but only trace
levels of Mad2.112 Developmental Cell 16, 105–117, January 20, 2009 ª2009 ElsevDISCUSSION
Unattached Kinetochores Catalyze Production
of a ‘‘Wait Anaphase’’ Inhibitor
While unattached kinetochores have been widely inferred to be
the source of a ‘‘wait anaphase’’ mitotic checkpoint inhibitor,
we have now demonstrated that kinetochores can, in fact,ier Inc.
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Figure 6. Unattached Kinetochores Facilitate BubR1, Bub3, and Mad2 Association with APC/CCdc20
(A) APC/C was incubated with preincubated combinations of Cdc20, Mad2, BubR1, Bub3, and chromosomes, recovered, peptide-eluted from Affiprep beads,
and analyzed for bound components by immunoblotting.
(B–E) APC/C was incubated with Cdc20 and increasing amounts of BubR1, Bub3, and Mad2wt (or Mad2RQ) either in the (blue squares) presence or (red triangles)
absence of chromosomes, and treated as in (A). The amounts of eluted (B) BubR1, (C) Bub3, and (D) Mad2wt (or Mad2RQ) were measured against a dilution series
of purified protein and quantified relative to the amount of Cdc20 bound to APC/C. Values were plotted as fold change over the initial (13) nonchromosome incu-
bated eluted amounts. (E) The relative stoichiometry of BubR1 molecules to Mad2 molecules associated with the APC/C complex. BubR1 relative stoichiometry
toMad2 increased above 1:1 when chromosomes were present, but remained approximately 1:1 or belowwhenMad2wt was replacedwithMad2RQ regardless of
the presence of chromosomes.
(F) APC/C incubated with combinations of Cdc20, Mad2, BubR1, Bub3, and chromosomes was recovered, eluted from Affiprep beads, fractionated over
a sucrose gradient, and analyzed by immunoblotting for bound components.catalyze production of an initial Mad2-Cdc20 inhibitor, signifi-
cantly accelerating the initial rate of its production. Unattached
kinetochores did not affect inhibition by Bub3/BubR1 in the
absence of Mad2. Production of at least two inhibitors can
be enhanced by unattached kinetochores: one containing diffus-
ible Cdc20 and another in which Cdc20 is already bound in
a megadalton complex to APC/C, consistent with reports that
Cdc20 and checkpoint proteins are present in two complexes
with differing sizes during mitosis (Braunstein et al., 2007;
Morrow et al., 2005; Sudakin et al., 2001; Wang et al., 2006).
Both inhibitors prevent recognition by APC/C of cyclin B as an
ubiquitination substrate. Disruption of cyclin B ubiquitination by
a kinetochore-derived inhibitor even while Cdc20 remains boundDevelopto APC/C provides a potential explanation for the differential
timing of destruction of cyclins A and B. Instead of simple
sequestration of Cdc20, a kinetochore-derived mitotic check-
point inhibitor bound to APC/CCdc20 may block recognition
of cyclin B as an ubiquitination substrate, while permitting
APC/CCdc20-mediated ubiquitination and destruction of cyclin A,
an event that is known to initiate immediately after mitotic entry
(den Elzen and Pines, 2001; Geley et al., 2001).
Despite amplification of Cdc20 inhibition when equal molar
levels of BubR1, Mad2, and Cdc20 were added, we found no
evidence for assembly of a quaternary MCC-like complex as
a bona fide inhibitor produced by unattached kinetochores.
Rather, almost all Cdc20 shifted to a complex comigrating withmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevier Inc. 113
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(A–F) (A) Individual components or (B–E) combinations of Cdc20, Mad2, BubR1, Bub3, and/or chromosomes were incubated for 1 hr and subsequently fraction-
ated over a Superose-6 filtration column. (E) Mixtures containing chromosomes were removed by pelleting the chromosomes prior to loading onto the column.
Fractions eluted from the columnwere analyzed for BubR1, Bub3, Cdc20, andMad2 content by immunoblotting for those components. (F) Amodel for generation
of a ‘‘wait anaphase’’ mitotic checkpoint inhibitor by sequential production of Mad2-Cdc20 and BubR1-Cdc20 inhibitors. Cytosolic Mad2 in an initially open
conformation is recruited to unattached kinetochores via an immobilized Mad1:Mad2 heterodimer. This second molecule of Mad2 binds in an activated confor-
mation that is poised for capture of Cdc20 either while kinetochore bound or after release. This transient Mad2-Cdc20 complex promotes handoff of Cdc20 to
BubR1, thereby inhibiting the ability of that Cdc20 to activate ubiquitination by APC/C of cyclin B, both by sequestering Cdc20 from APC/C and by inhibiting
Cdc20 while APC/C bound.the majority of BubR1 but containing very little Mad2 (Figure 7E).
Also arguing against a contribution in kinetochore-derived
checkpoint signaling,wenote thatMCC-like complexes in animal
cells are present outside of mitosis (Sudakin et al., 2001), and
their formation in yeast continues in the absence of a functional
centromere/kinetochore (Fraschini et al., 2001). All of this
supports an MCC-like, premade Cdc20 inhibitor produced in
a kinetochore-independent manner in interphase that restrains
APC/C ubiquitination activity for cyclin B just after mitotic entry,
which has been referred to as a ‘‘timer’’ (Meraldi et al., 2004).
More importantly, at physiologically relevant concentrations
of unattached kinetochores and Mad2, chromosomes catalyzed
production of Cdc20 inhibition of cyclin B recognition by APC/C
by at least 8-fold relative to inhibitors formed spontaneously in
the absence of chromosomes. The actual in vivo effect is likely
to be much greater than what we have observed in vitro, since
chromosome purification resulted in partial loss of signaling
molecules from kinetochores, including a proportion of Mad1
and kinases that include Bub1, BubR1, and Aurora B.
Sequentially Produced Mitotic Checkpoint Inhibitors
Initiated by a Mad1/Mad2 Template at Kinetochores
Chromosome amplification of Cdc20 inhibition required Mad1
recruitment ofMad2 to kinetochores anddimerization-competent
Mad2 (Figures 3E and 3F), thereby providing a direct demonstra-114 Developmental Cell 16, 105–117, January 20, 2009 ª2009 Elsevtion that a Mad1:Mad2 core complex recruits and converts
soluble ‘‘inactive’’ Mad2 into a more potent inhibitor of Cdc20.
At least part of this is from action of kinetochores on Mad2.
Although it has previously been argued that the kinetochore
may sensitize the APC/C for checkpoint-mediated inhibition
(Acquaviva et al., 2004; Sudakin et al., 2001), direct contact of
chromosomes with APC/C was not required to amplify inhibition
(Figures 5A and 5B). While we by no means exclude a kineto-
chore-dependent function of BubR1 from roles in microtubule
attachment and chromosome alignment (Ditchfield et al., 2003;
Elowe et al., 2007; Lampson and Kapoor, 2005) or from further
amplification of a kinetochore derived signal (Mao et al., 2003),
kinetochore-mediated enhancement of Cdc20 inhibition did not
require BubR1 localization to or contact with kinetochores.
We conclude that immobilized, kinetochore-bound Mad1/Mad2,
but notBubR1,catalyzesconversionat thekinetochoreof soluble,
open Mad2 into a formwith its seatbelt domain poised for Cdc20
capture. Further support for this conclusion includes evidence
that kinetochore-bound BubR1 is nonessential, as reported by
the accompanying report from Van Deursen and colleagues
(Malureanu et al., 2009 [this issue of Developmental Cell]).
Moreover, incubation of physiologically relevant concentra-
tions of eachcomponent ultimately producedmostCdc20bound
to BubR1, not Mad2, whether or not chromosomes were present
(Figures 7D and 7E). In fact, amplification of Cdc20 inhibition byier Inc.
Developmental Cell
Catalytic Kinetochores Generate a Cdc20 Inhibitorunattached kinetochores was accompanied by a shift to a more
rapidly eluting Bub3/BubR1-Cdc20 complex, without a stable
pool of Mad2-Cdc20. Evidence from Pines and colleagues also
demonstrated thatmost Cdc20 is complexedwith BubR1 in vivo,
rather than Mad2 (Nilsson et al., 2008). We propose a model
from all of this (Figure 7F) in which Mad1/Mad2 immobilized at
kinetochores templates conversion of an inactive, open Mad2
to one capable of transient capture of Cdc20 followed by relay
to BubR1 as sequentially produced mitotic checkpoint inhibitors
that may be soluble or APC/C bound. This evidence supports
Mad2-Cdc20, and perhaps an MCC-like complex, as a transient
intermediate in kinetochore-mediated checkpoint signaling and
one that is a precursor to BubR1-Cdc20. Further, Bub3/BubR1
binds to APC/C, but only in a Mad2-dependent manner that is
stimulated by unattached kinetochores (Figure 6A), demon-
strating that kinetochores facilitate loading of Bub3/BubR1
onto APC/C. That BubR1-APC/CCdc20 is produced indirectly by
unattached kinetochores as the final Cdc20 inhibitor would
also support suggestions that BubR1 acts as a nonproductive
pseudosubstrate of the APC/C (Burton and Solomon, 2007) or
mediates Cdc20 proteolytic turnover (King et al., 2007; Nilsson
et al., 2008; Pan and Chen, 2004).
Combining kinetochore-derived Bub3/BubR1-Cdc20 with
evidence for two Cdc20 binding sites on BubR1 (Davenport
et al., 2006) further suggests that the spontaneous and kineto-
chore-derived Bub3/BubR1-Cdc20 complexes may represent
generation of Cdc20 bound at the two different sites, respec-
tively, a point now testable with the appropriate BubR1 mutants.
EXPERIMENTAL PROCEDURES
Protein Purification
Recombinant proteins His-E1, His-UbcH10, His-Mad2wt, His-Mad2RQ, His-
Mad2DC, His-Mad2RQ-DC, and His-Myc-Cyclin B1-102 were purified from
bacteria after induction, while His-Cdc20, His-Cdh1, His-Bub3, and GST-
BubR1were purified from SF9/Hi5 insect cells after baculovirus infection using
HIS tag purification as previously described (Tang and Yu, 2004). GST-BubR1
purified over glutathione sepharose beadswas eluted by PreScission protease
digestion to cleave the GST tag and was separated from oligomeric species by
gel filtration. APC/C was immunoprecipitated from Xenopus egg extracts
cycled into interphase with calcium addition, or from checkpoint-active mitotic
extracts after sperm and nocodazole addition.
Chromosome Purification
HeLa cells stably expressing YFP-H2Bwere treatedwith 50 ng/ml colcemid for
16 hr. Mitotic cells were collected by shake-off and subjected to hypotonic
conditions in modified PME buffer (MPME; 5 mM PIPES [pH 7.2], 10 mM
NaCl, 5 mM MgCl2, 0.5 mM EGTA, and 2 mM EDTA). The swollen cells were
resuspended in 10 volumes of MPME buffer supplemented with 10 mg/ml
LPC, 0.5 mM spermine, 1 mM spermidine, 10 mM NaF, 1 mM Na3VO4, 1 mM
PMSF, and 0.1% digitonin. The cells were disrupted using a dounce homoge-
nizer to produce an initial lysate (total lysate). The lysate was centrifuged
at 900 3 g for 1 min to pellet intact nuclei and cell debris (cleared lysate).
The NaCl concentration of the solution was elevated to 100 mM (hsMPME),
and the lysate was placed over a sucrose step gradient (30%–40%–50%–
60%) prepared with supplemented hsMPME and centrifuged for 15 min
at 5000 3 g. The flocculent white material at the 40%–50% and 50%–60%
interface containing chromosomes was harvested (first sucrose gradient).
The chromosomes were washed in 8 volumes of supplemented hsMPME
buffer, sedimented for 15 min at 2900 3 g, suspended in supplemented
hsMPME, placed over a second sucrose gradient, and reharvested as
described above. The chromosomes were washed a second time and resus-
pended in 10 volumes of chromosome storage buffer (hsMPME containingDevelop50% sucrose, 0.5 mM spermine, 10 mM NaF, 1 mM Na3VO4, 10 mg/ml LPC),
aliquoted, frozen in liquid nitrogen, and stored at 80C.
APC/C Ubiquitination/Depletion Assays
APC/C ubiquitination assays were performed as previously described (Tang
and Yu, 2004), utilizing different anti-Cdc27 antibodies depending on whether
ubiquitination (Fang et al., 1998a) or depletion of cyclin B was measured
(Tugendreich et al., 1995). To analyze the depletion assays, film exposures
within a nearly linear range based on an internal loading gradient of inactive
APC/Cwere selected. The intensity of bands corresponding to unubiquitinated
cyclin B on immunoblots was quantified using NIH Image J software. The
intensities of each lane were normalized against inactive APC/C (no Cdc20
added: 0%) and fully active APC/C (with Cdc20, no inhibitors added: 100%).
Each depletion assay was repeated at least in triplicate and the average rep-
resented in graph format, with bars representing standard error of the mean.
Immunofluorescence of Chromosomes
Purified chromosomes were fixed in formaldehyde, placed over a 33% glyc-
erol cushion, and sedimented onto coverslips by centrifugation for 20 min at
5500 3 g. The chromosomes were subsequently fixed in ice-cold methanol
and processed as described (Weaver et al., 2003). The coverslips were stained
with the following antibodies: Hpx anti-CENP-E (Brown et al., 1996), sheep
SB1 anti-Bub1 (Taylor et al., 2001), BB3-8 anti-Mad1 (De Antoni et al.,
2005), rabbit anti-Mad2 (Kops et al., 2004), and ACA sera for identifying centro-
meres (Antibodies Inc.) Chromosomes were imaged using a DeltaVision
deconvolution microscope (Applied Precision). Optical sections were taken
at 0.15 intervals and deconvolved using SoftWoRx software (Applied Preci-
sion). The images were generated by projecting the sum of the stack of decon-
volved images. Images were processed after equivalent scaling.
Labeling of Mad2 and Its Localization onto Kinetochores
Mad2 and mutants of it were fluorescently labeled using FluoReporter Rhoda-
mine Red-X Protein Labeling Kit by Molecular Probes. Equivalently labeled
batches of Mad2 were selected. Chromosomes were incubated with 480 nM
rhodamine-labeledMad2 fractions for 1 hr at room temperature. ForMad1 anti-
body blocking, the chromosomes were first incubated with the Mad1 antibody
for 10 min and subsequently with the labeled Mad2. The chromosomes were
treated for imaging as described above. Kinetochore fluorescence was quan-
tified using the average intensity of traced kinetochore shape, asdetermined by
ACA staining, using MetaMorph Imaging software (Molecular Devices).
APC/C Complex Affinity, Elution, and Sucrose Sedimentation
APC/Cwas immunoprecipitated using apeptide-derivedCdc27 antibody (Her-
zog and Peters, 2005) conjugated to Affiprep Protein A (BioRad) beads for 2 hr
from Xenopus interphase extracts. The washed APC/C beads were incubated
with recombinant checkpoint proteins for 1 hr at room temperature. The beads
werewashed twicewith 20 volumes of TBSbuffer to remove unboundproteins.
The APC/C complex was eluted from the beads by Cdc27 peptide competition
as described (Herzog and Peters, 2005) and analyzed by immunoblotting.
Sucrose sedimentation of APC/C complexes was performed by scaling up
APC/C elution 5-fold and placing the eluate over a 5%–35% sucrose gradient.
The gradients were centrifuged for 4 hr at 50,000 rpm in a Beckman tabletop
ultracentrifuge with TLS55 swinging bucket rotor. The fractions were collected
from the top, andproteins in each fractionwereprecipitatedwith trichloroacetic
acid (TCA) before used in immunoblotting.
Gel Filtration of Complexes of Mad2, BubR1, Bub3 and Cdc20
Equimolar combinations of BubR1, Bub3, Cdc20, and Mad2 proteins were
incubated with or without purified mitotic chromosomes for 30 min at room
temperature, and protein complexes generated were resolved by Superose
6 gel filtration. Proteins in each column fraction were concentrated by TCA
precipitation and analyzed by immunoblotting.
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